US Map / South Carolina
State SC

Clinical Trials in South Carolina

Recruiting clinical trials with at least one study location in South Carolina. Data updated daily from ClinicalTrials.gov.

Total Trials
164
Recruiting Now
164
← Back to US Map
Top Conditions in South Carolina
Malignant Solid Neoplasm (4)Prostate Cancer (3)Atopic Dermatitis (3)Colorectal Cancer (3)Triple Negative Breast Cancer (3)Lung Non-Small Cell Carcinoma (2)Melanoma (2)Obesity (2)Weight Loss (2)Myasthenia Gravis (2)Hematopoietic and Lymphatic System Neoplasm (2)Acute Myeloid Leukemia (2)
NCT02227251 Phase 2
Recruiting
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Ly...
Condition
Diffuse Large B-cell Lymphoma
Enrollment
244 pts
Location
United States, Australia, Austria
Sponsor
Karyopharm Therapeutics Inc
View Trial →
NCT05948566 Phase 2
Recruiting
Strategy for Improving Stroke Treatment Response
Condition
Ischemic Stroke
Enrollment
300 pts
Location
United States
Sponsor
Translational Sciences, Inc.
View Trial →
NCT05702853 Phase 1, Phase 2
Recruiting
Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With C...
Condition
B-cell Non Hodgkin Lymphoma
Enrollment
27 pts
Location
United States
Sponsor
Medical University of South Ca
View Trial →
NCT02852031 N/A
Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart...
Condition
Hypoplastic Left Heart Syndrome (HLHS)
Enrollment
1,000 pts
Location
United States, Canada, United Kingdom
Sponsor
Children's Hospital Medical Ce
View Trial →
NCT07028853 Phase 3
Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrom...
Condition
Metastatic Castration Sensitive Prostate Cancer (mCSPC)
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
View Trial →
NCT06152575 Phase 3
Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in P...
Condition
Multiple Myeloma
Enrollment
492 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
View Trial →
NCT05064319 Phase 2
Recruiting
Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and ...
Condition
Bipolar Disorder
Enrollment
68 pts
Location
United States
Sponsor
Medical University of South Ca
View Trial →
NCT05793151 N/A
Recruiting
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Ti...
Condition
Head and Neck Cancer
Enrollment
532 pts
Location
United States
Sponsor
Medical University of South Ca
View Trial →
NCT06966700 Phase 3
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Br...
Condition
Breast Neoplasms
Enrollment
2,400 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT04996875 Phase 2
Recruiting
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Condition
Advanced Systemic Mastocytosis (AdvSM)
Enrollment
140 pts
Location
United States, Australia, Austria
Sponsor
Cogent Biosciences, Inc.
View Trial →
NCT07226011 N/A
Recruiting
Accelerated High-Dose tDCS for Depression
Condition
Major Depression
Enrollment
20 pts
Location
United States
Sponsor
Medical University of South Ca
View Trial →
NCT02679144 Phase 2
Recruiting
Neuroblastoma Maintenance Therapy Trial
Condition
Neuroblastoma
Enrollment
441 pts
Location
United States, Canada
Sponsor
Giselle Sholler
View Trial →
NCT05591118 Phase 3
Recruiting
Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy
Condition
Pulmonary Embolism
Enrollment
500 pts
Location
United States
Sponsor
NYU Langone Health
View Trial →
NCT05382338 Phase 3
Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hear...
Condition
Childhood Medulloblastoma
Enrollment
225 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
View Trial →
NCT07288138 Phase 2
Recruiting
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicar...
Condition
Metabolic Dysfunction-associated Steatohepatitis
Enrollment
160 pts
Location
United States
Sponsor
Eccogene
View Trial →
NCT04585750 Phase 1, Phase 2
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP5...
Condition
Advanced Solid Tumor
Enrollment
300 pts
Location
United States, Australia, France
Sponsor
PMV Pharmaceuticals, Inc
View Trial →
NCT07449923 Phase 3
Recruiting
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1...
Condition
Diabetic Macular Edema
Enrollment
240 pts
Location
United States
Sponsor
EyePoint Pharmaceuticals, Inc.
View Trial →
NCT07199569 Phase 2
Recruiting
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production C...
Condition
Monkeypox (Mpox)
Enrollment
744 pts
Location
United States
Sponsor
Bavarian Nordic
View Trial →
NCT06258590 N/A
Recruiting
taVNS for Anxiety in ASD
Condition
Autism Spectrum Disorder
Enrollment
10 pts
Location
United States
Sponsor
Medical University of South Ca
View Trial →
NCT07265479 Phase 3
Recruiting
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participant...
Condition
Atopic Dermatitis
Enrollment
180 pts
Location
United States, Canada
Sponsor
Organon and Co
View Trial →
NCT04485013 Phase 1
Recruiting
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Condition
Cancer
Enrollment
240 pts
Location
United States
Sponsor
Tizona Therapeutics, Inc
View Trial →
NCT06297291 N/A
Recruiting
Global Paradise System US Post Approval Study
Condition
Hypertension
Enrollment
1,000 pts
Location
United States
Sponsor
ReCor Medical, Inc.
View Trial →
NCT03968614 N/A
Recruiting
Electrical DN as an Adjunct to Eccentric Exercise, Stretching + MT for Achilles ...
Condition
Achilles Tendinopathy
Enrollment
110 pts
Location
United States
Sponsor
Alabama Physical Therapy & Acu
View Trial →
NCT03747458 Phase 3
Recruiting
OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps
Condition
Bilateral Nasal Polyposis
Enrollment
72 pts
Location
United States, Argentina
Sponsor
Optinose US Inc.
View Trial →
NCT06567743 Phase 2
Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec ...
Condition
High-Risk Non-Muscle-Invasive Bladder Cancer
Enrollment
325 pts
Location
United States
Sponsor
CG Oncology, Inc.
View Trial →
Page 6 of 7 — 164 trials total
← Prev Next →